These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7033947)

  • 1. A comparative study of the efficacy of indapamide and bendrofluazide given in combination with atenolol.
    Zacharias FJ
    Postgrad Med J; 1981; 57 Suppl 2():51-2. PubMed ID: 7033947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antihypertensive effects of indapamide and metoprolol.
    Kubik MM; Coote JH
    Postgrad Med J; 1981; 57 Suppl 2():44-50. PubMed ID: 7033946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination hypotensive therapy with atenolol, bendrofluazide and hydrallazine.
    Wilcox RG
    Postgrad Med J; 1977; 53 Suppl 3():128-33. PubMed ID: 337267
    [No Abstract]   [Full Text] [Related]  

  • 5. [Atenelol and bendrofluazide in the treatment of medium and severe hypertension (preliminary report)].
    Braendli B; Bucher HJ; Nager F; Truniger B
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1976-8. PubMed ID: 373099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
    Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
    [No Abstract]   [Full Text] [Related]  

  • 7. You should treat patients over the age of 80 who have hypertension.
    Lundberg GD
    Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma renin concentration and the hypotensive effect of bendrofluazide and of atenolol.
    Fagard R; Amery A; Deplaen JF; Lijnen P; Missotten A
    Clin Sci Mol Med Suppl; 1976 Dec; 3():215s-217s. PubMed ID: 799551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'third drug' trial: a comparative study of anti-hypertensive agents added to treatment when blood pressure is uncontrolled by a beta-blocker plus thiazide diuretic.
    McAreavey D; Ramsay LE; Latham L; Lorimer AR; McLaren D; Reid JL; Robertson JI; Robertson MP; Weir RJ
    J Hypertens Suppl; 1983 Dec; 1(2):116-9. PubMed ID: 6400110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single doses of enalapril and atenolol in hypertensive patients treated with bendrofluazide.
    Webster J; Robb OJ; Witte K; Petrie JC
    J Hypertens; 1987 Aug; 5(4):457-60. PubMed ID: 2822797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indapamide and bendrofluazide: a comparison in the management of essential hypertension.
    Bing RF; Russell GI; Swales JD; Thurston H
    Br J Clin Pharmacol; 1981 Dec; 12(6):883-6. PubMed ID: 7041937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of captopril and atenolol in moderately severe essential hypertension.
    Carey M; Blake S
    Postgrad Med J; 1986; 62 Suppl 1():111-2. PubMed ID: 3317338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atenolol and bendrofluazide in hypertension.
    Petrie JC; Galloway DB; Webster J; Simpson WT; Lewis JA
    Br Med J; 1975 Oct; 4(5989):133-5. PubMed ID: 1104047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical results of the combined use of a diuretic and a beta-blocking agent in the therapy of arterial hypertension].
    Allegri M; Magni S; Freggiaro V; Stirace T
    Clin Ter; 1982 Jan; 100(1):11-9. PubMed ID: 7151366
    [No Abstract]   [Full Text] [Related]  

  • 16. A multicentre open trial indapamide in general practice.
    Bowker CH; Murphy MA
    Postgrad Med J; 1981; 57 Suppl 2():53-6. PubMed ID: 7033948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antihypertensive action of indapamide: results of a French multicentre study of 2,184 ambulant patients.
    Mimran A; Zambrowski JJ; Coppolani T
    Postgrad Med J; 1981; 57 Suppl 2():60-3. PubMed ID: 6119686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.
    Wilcox RG; Mitchell JR
    Br Med J; 1977 Aug; 2(6086):547-50. PubMed ID: 329948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atenolol withdrawal in patients on triple antihypertensive therapy.
    Bevan EG; Pringle SD; Waller PC; Herrick AL; Findlay JG; Murray GD; Carmichael HA; Lorimer AR; Reid JL; Weir RJ
    J Hum Hypertens; 1993 Feb; 7(1):89-93. PubMed ID: 8450527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study comparing indapamide with cyclopenthiazide in geriatric patients.
    Khan AU
    Postgrad Med J; 1981; 57 Suppl 2():42-3. PubMed ID: 7033945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.